Nitric oxide synthase gene transfer and treatment of restenosis: From bench to bedside

European Journal of Clinical Pharmacology

Volumn 62, Issue SUPPL. 13, 2006, Pages 83-89

  Von Der Leyen, Heiko E ^a,c   Chew, Nancy ^b  

^a Hannover Clinical Trial Center GmbH   (Germany)

^b Regulatory Affairs North America LLC   (United States)

^c HCTC GmbH   (Germany)

Author keywords

Gene therapy; Nitric oxide synthase; Restenosis

Indexed keywords

3BETA [N (N,N DIMETHYLAMINOETHANE)CARBAMOYL]CHOLESTEROL; CAR MP583; CHOLESTEROL DERIVATIVE; DC 30; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPLEX; LIPOSOME; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ADENOVIRUS VECTOR; CAR MP 583;

ADENOVIRUS VECTOR; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; CAROTID ARTERY INJURY; CLINICAL PRACTICE; CONFERENCE PAPER; CORONARY STENT; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; EXPRESSION VECTOR; GENE TRANSFER; HERPESVIRUS VECTOR; IMPLANTATION; IN-STENT RESTENOSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RODENT; TOXICOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR LESION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS VECTOR; RESTENOSIS; SINGLE DRUG DOSE;

EID: 33344477600     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0021-y     Document Type: Conference Paper

References (35)

1. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
2. Vane JR, Änggård EE, Botting RM (1990) Regulatory functions of the vascular endothelium. N Engl J Med 323:27-36
3. De Caterina R, Libby P, Peng HB, Thannickal J, Rajavashisth TB, Gimbrone MAJ, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68
4. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777
5. Mooradian DL, Hutsell TC, Keefer LK (1995) Nitric oxide (NO) donor molecules: effect of NO release rates on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25:674-678
6. Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP (1997) Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96:934-940
7. Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100:2153-2157
8. Lamas S, Marsden PA, Li GK, Tempst P, Michel T (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A 89:6348-6352
9. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH (1992) Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A 89:7611-6715
10. Nathan C, Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918
11. von der Leyen H, Mann MJ, Dzau VJ (1998) Gene therapy of cardiovascular disorders. In: Alexander RW, Schlant RC, and Fuster V (eds) Hurst's the heart, 9th edn. McGraw-Hill, New York, pp 213-225
12. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ (1995) Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial-cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 92:1137-1141
13. Shears LL, Kibbe MR, Murdock AD, Billiar TR, Lizonova A, Kovesdi I, Watkins SC, Tzeng E (1998) Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs. J Am Coll Surg 187:295-306
14. Mann MJ, Morishita R, Gibbons GH, von der Leyen HE, Dzau VJ (1997) DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes. Mol Cell Biochem 172:3-12
15. Tzeng E, Shears LL, Robins PD, Pitt BR, Geller DA, Watkins SC, Simmons RL, Billiar TR (1996) Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia. Mol Med 2:211-225
16. Kullo IJ, Mozes G, Schwartz RS, Gloviczki P, Crotty TB, Barber DA, Katusic ZS, O'Brien T (1997) Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity. Circulation 96:2254-2261
17. Shears LL, Kawaharada N, Tzeng E, Billiar TR, Watkins SC, Kovesdi I, Lizonova A, Pham SM (1997) Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 100:2035-2042
18. Janssens S, Flaherty D, Nong Z, Varenne O, van Pelt N, Haustermans C, Zoldhelyi P, Gerard R, Collen D (1998) Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97:1274-1281
19. Varenne O, Pislaru S, Gillijns H, Van Pelt N, Gerard RD, Zoldhelyi P, Van de Werf F, Collen D, Janssens SP (1998) Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 98:919-926
20. Chen L, Daum G, Forough R, Clowes M, Walter U, Clowes AW (1998) Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res 82:862-870
21. Raman KG, Shapiro RA, Tzeng E, Kibbe MR (2004) Adenovirus-mediated nitric oxide synthase gene transfer. Methods Mol Biol 279:225-234
22. Muhs A, Heublein B, Rüdiger M, Schletter J, Sturm M, Schrader J, von der Leyen HE (2003) Inhibition of vascular instent plaque formation by iNOS-lipoplex mediated gene therapy in mini-pigs. Hum Gene Ther 14:375-384
23. von der Leyen HE, Muhs A, Schrader J, Hausmann D, Sturm M, Heublein B (2000) Inhibition of in-stent plaque formation by inducible nitric oxide synthase-lipoplex-mediated gene therapy in a pig femoral artery stent model (abstract). J Am Coll Cardiol 35(Suppl A):280A
24. Varenne O, Gerard RD, Sinnaeve P, Gillijns H, Collen D, Janssens S (1999) Percutaneous adenoviral gene transfer into porcine coronary arteries: is catheter-based delivery adapted to coronary circulation? Hum Gene Ther 10:1105-1115
25. Barath P, Popov A, Dillehay GL, Matos G, McKiernant T (1997) Infiltrator angioplasty balloon catheter: a device for combined angioplasty and intramural site-specific treatment. Cathet Cardiovasc Diagn 41:333-341
26. Iwashina M, Shichiri M, Marumo F, Hirata Y (1998) Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 98:1212-1218
27. Wang BY, Ho HK, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH, Tsao PS, Cooke JP (1999) Regression of atherosclerosis. Role of nitric oxide and apoptosis. Circulation 99:1236-1241
28. Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH (1998) Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 4:222-227
29. Gad SC (2000) Large animal toxicology: introduction and general principles. Int J Toxicol 19:129-132
30. Kemi M, Keenan KP, McCoy C, Hoe CM, Soper KA, Ballam GC, van Zwieten MJ (2000) The relative protective effects of moderate dietary restriction versus dietary modification on spontaneous cardiomyopathy in male Sprague-Dawley rats. Toxicol Pathol 28:285-296
31. Luo JD, Wang YY, Fu WL, Wu J, Chen AF (2004) Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 110:2484-2493
32. von der Leyen HE, Dzau VJ (2001) Therapeutic potential of nitric oxide synthase gene manipulation. Circulation 103:2760-2765
33. RAC (2001) Minutes of the recombinant DNA advisory committee meeting on December 13 & 15, 2000. Hum Gene Ther 12:1559-1584
34. Bundesärztekammer (1995) Richtlinien zum Gentransfer in menschlichen Körperzellen. Deut Ärztebl 11:A789-A794
35. Fichtlscherer S, Mügge A, Hanefeld C, Rupprecht HJ, Hamm CW, von der Leyen HE, Zeiher A (2000) REGENT 1 (Restenosis Gene Therapy Trial): first clinical results after local intracoronary application of iNOS-lipoplex-gene product. Eur Heart J 4(Suppl):252